| 2018 ESC/EACTS Guidelines on myocardial revascularization FJ Neumann, M Sousa-Uva, A Ahlsson, F Alfonso, AP Banning, ... Russian Journal of Cardiology, 151-226, 2019 | 7790 | 2019 |
| Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio … Developed with the Special Contribution of the European Association for ... European heart journal 31 (20), 2501-2555, 2010 | 3674 | 2010 |
| 2018 ESC/EACTS Guidelines on myocardial revascularization M Sousa-Uva, FJ Neumann, A Ahlsson, F Alfonso, AP Banning, ... European Journal of Cardio-Thoracic Surgery 55 (1), 4-90, 2019 | 654 | 2019 |
| Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness P Kampus, M Serg, J Kals, M Zagura, P Muda, K Karu, M Zilmer, J Eha Hypertension 57 (6), 1122-1128, 2011 | 266 | 2011 |
| Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure. M Kivikko, S Antila, J Eha, L Lehtonen, PJ Pentikäinen International journal of clinical pharmacology and therapeutics 40 (10), 465-471, 2002 | 244 | 2002 |
| Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure M Kivikko, S Antila, J Eha, L Lehtonen, PJ Pentikäinen The Journal of Clinical Pharmacology 42 (1), 43-51, 2002 | 210 | 2002 |
| Vitamin D reduces deposition of advanced glycation end-products in the aortic wall and systemic oxidative stress in diabetic rats E Salum, J Kals, P Kampus, T Salum, K Zilmer, M Aunapuu, A Arend, ... Diabetes research and clinical practice 100 (2), 243-249, 2013 | 125 | 2013 |
| Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan S Antila, M Kivikko, L Lehtonen, J Eha, A Heikkilä, P Pohjanjousi, ... British journal of clinical pharmacology 57 (4), 412-415, 2004 | 90 | 2004 |
| Inverse relations of serum phosphatidylcholines and lysophosphatidylcholines with vascular damage and heart rate in patients with atherosclerosis K Paapstel, J Kals, J Eha, K Tootsi, A Ottas, A Piir, M Jakobson, J Lieberg, ... Nutrition, Metabolism and Cardiovascular Diseases 28 (1), 44-52, 2018 | 85 | 2018 |
| Aortic stiffness and vitamin D are independent markers of aortic calcification in patients with peripheral arterial disease and in healthy subjects M Zagura, M Serg, P Kampus, M Zilmer, J Eha, E Unt, J Lieberg, ... European Journal of Vascular and Endovascular Surgery 42 (5), 689-695, 2011 | 83 | 2011 |
| Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes E Salum, P Kampus, M Zilmer, J Eha, M Butlin, AP Avolio, T Põdramägi, ... Cardiovascular diabetology 11, 1-8, 2012 | 80 | 2012 |
| Inflammation and oxidative stress are associated differently with endothelial function and arterial stiffness in healthy subjects and in patients with atherosclerosis J Kals, P Kampus, M Kals, A Pulges, R Teesalu, K Zilmer, T Kullisaar, ... Scandinavian Journal of Clinical and Laboratory Investigation 68 (7), 594-601, 2008 | 76 | 2008 |
| Oral levosimendan in patients with severe chronic heart failure—the PERSIST study MS Nieminen, JGF Cleland, J Eha, Y Belenkov, M Kivikko, P Põder, ... European journal of heart failure 10 (12), 1246-1254, 2008 | 70 | 2008 |
| Benefit-Risk Assessment of Crataegus Extract WS 1442: An Evidence-Based Review CJF Holubarsch, WS Colucci, J Eha American Journal of Cardiovascular Drugs 18, 25-36, 2018 | 62 | 2018 |
| Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology U Zeymer, P Ludman, N Danchin, P Kala, C Laroche, M Sadeghi, ... European heart journal 42 (44), 4536-4549, 2021 | 61 | 2021 |
| β2-microglobulin, a novel biomarker of peripheral arterial disease, independently predicts aortic stiffness in these patients J Kals, M Zagura, M Serg, P Kampus, K Zilmer, E Unt, J Lieberg, J Eha, ... Scandinavian journal of clinical and laboratory investigation 71 (4), 257-263, 2011 | 59 | 2011 |
| Pharmacodynamics and pharmacokinetics of oral levosimendan and its metabolites in patients with severe congestive heart failure: a dosing interval study P Põder, J Eha, S Sundberg, S Antila, M Heinpalu, I Loogna, Ü Planken, ... The Journal of Clinical Pharmacology 44 (10), 1143-1150, 2004 | 53 | 2004 |
| Recall by genotype and cascade screening for familial hypercholesterolemia in a population-based biobank from Estonia M Alver, M Palover, A Saar, K Läll, SM Zekavat, N Tõnisson, L Leitsalu, ... Genetics in Medicine 21 (5), 1173-1180, 2019 | 51 | 2019 |
| Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension M Serg, P Kampus, J Kals, M Zagura, M Zilmer, K Zilmer, T Kullisaar, ... Scandinavian journal of clinical and laboratory investigation 72 (5), 427-432, 2012 | 50 | 2012 |
| Metabolomic signature of arterial stiffness in male patients with peripheral arterial disease M Zagura, J Kals, K Kilk, M Serg, P Kampus, J Eha, U Soomets, M Zilmer Hypertension Research 38 (12), 840-846, 2015 | 49 | 2015 |
